# Study of GS-0415 and How It Works in People With HIV

> **NCT07719491** · PHASE1 · RECRUITING · sponsor: **Gilead Sciences** · enrollment: 112 (estimated)

## Conditions studied

- HIV -1 Infection

## Interventions

- **DRUG:** GS-0415
- **DRUG:** GS-0415 Placebo

## Key facts

- **NCT ID:** NCT07719491
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-22
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719491, "Study of GS-0415 and How It Works in People With HIV". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07719491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*